Sarah Likis Powell1, Erica Liebelt2. 1. Children's Hospital of Alabama, Birmingham, AL. Electronic address: sarah.powell@childrensal.org. 2. University of Alabama at Birmingham School of Medicine.
Abstract
OBJECTIVES: (a) Compare utilization of vancomycin in the ED prior to and after implementation of standardized treatment guideline and order template (STGOT); (b) assess the appropriate use as initial therapy based on indication versus admitting diagnosis. METHODS: Chart audits on all patients who received vancomycin and were admitted. Overall utilization and appropriateness of starting therapy were compared pre-and post-STGOT implementation. RESULTS: Overall utilization of vancomycin was 4% pre-STGOT compared to 3% post-STGOT; 98% of patients pre-STGOT compared to 99% post-STGOT received vancomycin appropriately. CONCLUSION: There was no difference in vancomycin utilization and appropriateness of initiating therapy after STGOT implementation.
OBJECTIVES: (a) Compare utilization of vancomycin in the ED prior to and after implementation of standardized treatment guideline and order template (STGOT); (b) assess the appropriate use as initial therapy based on indication versus admitting diagnosis. METHODS: Chart audits on all patients who received vancomycin and were admitted. Overall utilization and appropriateness of starting therapy were compared pre-and post-STGOT implementation. RESULTS: Overall utilization of vancomycin was 4% pre-STGOT compared to 3% post-STGOT; 98% of patients pre-STGOT compared to 99% post-STGOT received vancomycin appropriately. CONCLUSION: There was no difference in vancomycin utilization and appropriateness of initiating therapy after STGOT implementation.
Authors: D Donà; E Barbieri; M Daverio; R Lundin; C Giaquinto; T Zaoutis; M Sharland Journal: Antimicrob Resist Infect Control Date: 2020-01-03 Impact factor: 4.887